Open AccessSelective Serotonin Reuptake Inhibitors and Myocardial Infarction
Author(s) -
William H. Sauer,
Jesse A. Berlin,
Stephen E. Kimmel
Publication year - 2001
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/hc4101.097519
Subject(s) - medicine , odds ratio , depression (economics) , myocardial infarction , antidepressant , reuptake inhibitor , confidence interval , aspirin , family history , risk factor , body mass index , serotonin reuptake inhibitor , hippocampus , economics , macroeconomics
Depression is an independent risk factor for myocardial infarction (MI). Selective serotonin reuptake inhibitors (SSRIs) may reduce this risk through attenuation of serotonin-mediated platelet activation in addition to treatment of depression itself.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom